Abstracts - faqs.org

Abstracts

Business, general

Search abstracts:
Abstracts » Business, general

PAREXEL Int'l Corp

Article Abstract:

The shares of PAREXEL International Corp. have a sub par price appreciation potential over the 2010-2012 timeframe. The Waltham, Massachusetts-based company is a contract research organization with divisions in clinical research, consulting and marketing, and Perceptive Informatics.

Author: Schwed, Joel
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2008
Management and Public Relations, Consulting services, PAREXEL International Corp., PRXL

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Neurocrine Biosci

Article Abstract:

The price appreciation potential of the shares of Neurocrine Biosciences Inc. for the years 2010-2012 is discussed. The San Diego, California-based company develops drugs to treat disorders of the endocrine and nervous systems.

Author: Schwed, Joel
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2008
Commercial physical research, Biological products exc. diagnostic, Biotechnology industry, Biotechnology industries, Neurocrine Biosciences Inc.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA



Subjects list: United States, Evaluation, Stocks, Securities, Stock prices, Company securities, Analyst report
Similar abstracts:
  • Abstracts: AMCOL Int'l. Surmodics, Inc
  • Abstracts: Ameron Int'l Corp. Overseas Ship. Maritime industry
  • Abstracts: Angelica Corp. Panera Bread Co
  • Abstracts: Financial Services Industry. Amer. Express. Financial services industry
  • Abstracts: Auto parts (original equipment). American Axle
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.